Four weeks of Ledipasvir/Sofosbuvir plus Ribavirin with or without interferon gives very high and sustained cure rates in difficult to reach but easy to treat injecting drug users with chronic hepatitis C: final results of the 4WIDUC study: Journal of Hepatology

A L H Øvrehus, H. Krarup, Inge Birkemose, B. Mössner, P. B. Christensen

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerTHU-225
TidsskriftJournal of Hepatology
Vol/bind66
Udgave nummer1
Sider (fra-til)S287-S287
ISSN0168-8278
DOI
StatusUdgivet - 2017
Begivenhed The International Liver Congress / 52nd Annual meeting of the European Association for the Study of the Liver - Amsterdam, Holland
Varighed: 19 apr. 201723 apr. 2017

Konference

Konference The International Liver Congress / 52nd Annual meeting of the European Association for the Study of the Liver
Land/OmrådeHolland
ByAmsterdam
Periode19/04/201723/04/2017

Citationsformater